Merck Cancer Shot Gets FDA Approval: What to Know

Merck cancer shot gets FDA approval: What to know

The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's what we know.

A new shot for cancer is convenient, but poised to keep prices high

To keep Keytruda revenue flowing, Merck developed a new version of the cancer treatment drug, given as a shot under the skin, which the FDA approved Friday.

Injectable Cancer Drug Keytruda Qlex Gains FDA Approval

The U.S. Food and Drug Administration (FDA) has approved a new injected version of the cancer drug Keytruda (pembrolizumab) that may be easier for many patients to take than the older intravenous version of the medicine given through infusion.e60dc2a1-f33c-4a05-9b50-8e3e8e597629fee353f1-331e-4a9f-840f-a7cd77616e11e60dc2a1-f33c-4a05-9b50-8e3e8e5976290b23e637-fd0e-4e02-8a2e-1b920759f5ff The FDA approved the injected form, Keytruda Qlex, for a wide…

FDA Approves New Administration Method for Keytruda (pembrolizumab) - GO2 for Lung Cancer

Open the article to view the coverage from go2.org

FDA Approval of KEYTRUDA QLEX A New Frontier in Solid Tumor Treatment and Its Strategic Implications for Merck & Co.,...

Exploring the FDA Approval of KEYTRUDA QLEX: A New Avenue for Solid Tumor Treatment and Its Implications for Merck & Co., Inc.' In a significant advancement in cancer therapy, the U.S. Food and Drug Administration (FDA) has officially approved KEYTRUDA QLEX, a novel formulation combining pembrolizumab and berahyaluronidase alfa-pmph for subcutaneous use. Manufactured by Merck & Co., Inc., known as MSD outside the United States and Canada, this i…

Merck’s Injectable Version of Blockbuster Cancer Drug Keytruda Wins FDA Approval – RamaOnHealthcare

Keytruda Qlex, an injectable version of Merck’s cancer immunotherapy, can be administered in minutes compared to the 30 minutes needed to dose the original infused formulation. The FDA approval is based on clinical trial results showing the injectable formulation was comparable to infused Keytruda.A subcutaneously injected version of Merck cancer immunotherapy Keytruda is now FDA [...]